| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |